Cernostics Company
Cernostics is a life science company developing new molecular diagnostic tests to treat cancer.
Total Funding:
$65M
Technology:
Genetic Test & Molecular Diagnostics
Last Funding Type:
Private Equity
Estimated Revenue:
$1M to $10M
Founded Date:
01.01.2008
Industry:
Deep Diagnostics
Funding Status:
Early Stage Venture
Headquarters:
Danville, Pennsylvania, United States
Investors Number:
9